Variant report
Variant | esv2763580 |
---|---|
Chromosome Location | chr1:90824652-90835937 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7546709 | chr1:90824652-90824653 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs562456009 | chr1:90824664-90824665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189134690 | chr1:90824681-90824682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75863190 | chr1:90824683-90824684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573680139 | chr1:90824693-90824694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543914536 | chr1:90824702-90824703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140763402 | chr1:90824793-90824794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7515875 | chr1:90824823-90824824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544806652 | chr1:90824841-90824842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545309801 | chr1:90824844-90824845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192399919 | chr1:90824856-90824857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183824330 | chr1:90824871-90824872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549550438 | chr1:90824893-90824894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564784229 | chr1:90824896-90824897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567693481 | chr1:90824935-90824936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186606194 | chr1:90824951-90824952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547101100 | chr1:90824989-90824990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538529308 | chr1:90825014-90825015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34699885 | chr1:90825069-90825070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550252994 | chr1:90825084-90825085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571690571 | chr1:90825086-90825087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12124677 | chr1:90825103-90825104 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs34770961 | chr1:90825121-90825122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34716656 | chr1:90825128-90825129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558119052 | chr1:90825151-90825152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6428586 | chr1:90825173-90825174 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs6428587 | chr1:90825188-90825189 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs6428588 | chr1:90825206-90825207 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs573715889 | chr1:90825207-90825208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145890534 | chr1:90825225-90825226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138816620 | chr1:90825228-90825229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76213574 | chr1:90825230-90825231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544579859 | chr1:90825235-90825236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560496464 | chr1:90825309-90825310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539281290 | chr1:90825351-90825352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191413392 | chr1:90825372-90825373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375561194 | chr1:90825387-90825388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542910435 | chr1:90825576-90825577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561533858 | chr1:90825596-90825597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17131012 | chr1:90825613-90825614 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs147428038 | chr1:90825619-90825620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551996983 | chr1:90825643-90825644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138168790 | chr1:90825645-90825646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374688602 | chr1:90825674-90825675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149536782 | chr1:90825689-90825690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547811978 | chr1:90825747-90825748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566696114 | chr1:90825751-90825752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534105752 | chr1:90825761-90825762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144663000 | chr1:90825797-90825798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576295743 | chr1:90825816-90825817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 16397240 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:90824000-90824800 | Enhancers | GM12878-XiMat | blood |
2 | chr1:90824000-90825200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr1:90824000-90825200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr1:90825200-90826000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr1:90825400-90825600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr1:90825400-90826000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr1:90825600-90825800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr1:90825600-90825800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr1:90825600-90826000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr1:90825600-90826000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr1:90826000-90829000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr1:90828000-90828200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr1:90828000-90828200 | Enhancers | HMEC | breast |
14 | chr1:90829000-90829200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr1:90832600-90832800 | Enhancers | Aorta | Aorta |
16 | chr1:90832800-90835600 | Weak transcription | Aorta | Aorta |
17 | chr1:90835600-90836000 | Enhancers | Spleen | Spleen |
18 | chr1:90835600-90836600 | Enhancers | Aorta | Aorta |
19 | chr1:90835800-90836600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr1:90835800-90836800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr1:90835800-90838000 | Enhancers | Dnd41 | blood |